DOCS

$25.16+0.57 (+2.32%)

Market OpenAs of Mar 17, 6:54 PM UTC

Doximity, Inc.

Historical Price

Price (Line)
50-Day SMA
200-Day SMA
Synthesizing Whystock Narrative...
Loading Financials...

Peer Comparison

JNJUNHPFE

Whystock Valuation Model

Calculated using a trailing P/E relative model adjusted by sector ROE and historical growth.
Current Price$25.16
Potential Upside
7.7%
Whystock Fair Value$27.09
Price
UndervaluedFair ValueOvervalued

Fundamentals

SectorHealthcare
IndustryHealth Information Services

Doximity, Inc. operates as a digital platform for medical professionals in the United States. Its platform provides its members with digital tools built for medicine, that enables its members to collaborate with colleagues, stay up to date with the l...

Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$4.74B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
21.14
Beta
High-beta play. Expect amplified moves vs. the broad market.
1.44
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROIC
Elite ROE. Management converts capital into profit efficiently.
23.82%
Quick Ratio
Pristine liquidity. Sufficient cash to cover all near-term obligations.
6.00

Recent News

Simply Wall St.
Mar 14, 2026

Assessing Doximity (DOCS) Valuation After A Steep Share Price Pullback

Why Doximity (DOCS) Is Drawing Investor Attention Now Doximity (DOCS) has been on many investors’ watchlists after a steep share price decline over the past year. This has prompted fresh questions about how its current valuation lines up with its financial profile. See our latest analysis for Doximity. At a latest share price of US$24.37, Doximity’s recent pattern includes a 44.42% 3 month share price return decline and a 61.55% 1 year total shareholder return decline. This may indicate...

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
StockStory
Mar 12, 2026

2 Software Stocks with Solid Fundamentals and 1 We Turn Down

Software is eating the world, and virtually no business is left untouched by it. This secular theme makes SaaS companies attractive investment candidates but also comes with higher valuations that cause volatility. Unfortunately, the rich prices have haunted them over the past six months as the industry has shed 22%. This drop is a far cry from the S&P 500’s 3% ascent.

BEARISH
Negative press. News cycle fixated on risk factors or misses.
MT Newswires
Mar 9, 2026

Doximity's Early 2026 Portal Activity Points to Steady Demand, RBC Says

Doximity (DOCS) is poised to benefit from positive January and February web-traffic trends on its he

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Zacks
Mar 5, 2026

Hims and Hers Expands Its Technology Driven Consumer Health Platform

HIMS expands its tech-driven care platform with data-led Labs testing, new menopause and testosterone services and global expansion into Canada.

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
StockStory
Mar 3, 2026

Atlassian, C3.ai, Doximity, Braze, and Zeta Global Stocks Trade Up, What You Need To Know

A number of stocks jumped in the afternoon session after investors appeared to buy the dip amid heightened uncertainty triggered by resurgent inflation fears and escalating geopolitical tensions.

BEARISH
Negative press. News cycle fixated on risk factors or misses.